Patent US5145990A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5145990A Expired / Lapsed US ⏱️ 0.0 years remaining

Phosphorous containing dhp enzyme inhibitors

Assignee: Merck and Co Inc
•
Filing: 1991-01-09
•
Granted: 1992-09-08
•
Expires: 2011-01-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula: <IMAGE> wherein R1 is C2-C12 linear or branched unsubstituted alkyl; C1-C12 linear or branched substituted alkyl; C2-C12 linear or branched monoalkenyl; C2-C12 linear or branched alkynyl; C7-C20 aralkyl, wherein the alkyl chain is linear or branched C1-C8 and the aryl moiety is C6-C12; C4-C10 cycloalkylalkyl; C3-C7 cycloalkyl; wherein these values for R1, other than C2-C12 linear or branched unsubstituted alkyl, can be substituted by one or more of C1-C4 alkoxy, C3-C6 cycloalkyloxy, C3-C6 cycloalkylthio, C6-C12 aryloxy, C1-C4 alkylthio, C6-C12 arylthio, C7-C10 aralkyloxy, C7-C16 aralkyl-thio; and R5 is H or C1-C12 linear or branched alkyl; C2-C12 linear or branched monoalkenyl; C7-C20 aralkyl, wherein the alkyl chain is linear or branched C1-C8 and the aryl moiety is C6-C12; heterocyclic alkyl wherein the alkyl chain is linear or branched C1-C8 and the heterocyclic ring is 5-6 membered, optionally fused with a benzene ring, fully aromatic, containing 1 to 2 of oxygen, nitrogen or sulfur as heteroatoms; C4-C10 cycloalkylalkyl; C3-C7 cycloalkyl; wherein the values for R5 can be substituted by one or more of halo, hydroxy, carboxy, C1-C4 alkoxycarbonyl, C7-C16 arylalkoxycarbonyl, C3-C7 cycloalkyl, C1-C4 alkoxy, C6-C12 aryloxy, C3-C6 cycloalkyloxy, C3-C6 cycloalkylthio, amino, mono- or di- C1-C8 alkylamino, thio, C1-C4 alkylthio, C6-C12 arylthio, C7-C16 aralkylthio, or the radical -S-(CH2)nCH(NH2)COOH. These compounds have dehydropeptidase (DHP) enzyme inhibitor activity.

Inventors

  • 👤 William H. Parsons
  • 👤 William R. Schoen
  • 👤 Arthur A. Patchett

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 01:11
CPC Classifications
C; C07; C07F; C07F9/00; C07F9/02; C07F9/28; C07F9/30; C07F9/306; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/40; C07F9/301; C07F9/302; C07F9/303; C07F9/547; C07F9/553; C07F9/576; C07F9/58

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 373 words
A DHP inhibiting compound of Formula II: ##STR54## wherein R 1 is (a) C 2 -C 12 linear or branched unsubstituted alkyl; (b) C 2 -C 12 linear or branched substituted alkyl; (c) C 2 -C 12 linear or branched monoalkenyl; (d) C 2 -C 12 linear or branched alkynyl; (e) C 7 -C 20 aralkyl, wherein the alkyl chain is linear or branched C 1 -C 8 where N is 1 or 2 and the aryl moiety is C 6 -C 12 ; (f) C 3 -C 7 cycloalkyl; (g) C 4 -C 10 cycloalkylalkyl; wherein said above values for R 1 , excluding (a), can be substituted by one or more: C 1 -C 4 alkoxy, C 3 -C 6 cycloalkyloxy, C 3 -C 6 cycloalkylthio, C 6 -C 12 aryloxy, C 1 -C 4 alkylthio, C 6 -C 12 arylthio, C 7 -C 10 aralkyloxy, C 7 -C 16 aralkylthio; R 5 is (a) H or C 1 -C 12 linear or branched alkyl; (b) C 2 -C 12 linear or branched monoalkenyl; (c) C 7 -C 20 aralkyl, wherein the alkyl chain is linear or branched C 1 -C 8 and the aryl moiety is C 6 -C 12 ; (d) heterocyclic alkyl, wherein the alkyl chain is linear or branched C 1 -C 8 and the heterocyclic ring is 5-6 membered, aromatic, and containing 1-2 heteroatoms selected from the group consisting of O, N and S; (e) heterocyclic alkyl, wherein the alkyl chain is linear or branched C 1 -C 8 and the heterocyclic ring is 5-6 membered, aromatic, containing 1-2 heteroatoms selected from the group consisting of O, N and S, and the heterocyclic ring is fused with a benzene ring; wherein said above values for R 5 can be substituted by one or more: halo, hydroxy, carboxy, C 1 -C 4 alkoxycarbonyl, C 7 -C 16 arylalkoxycarbonyl, C 3 -C 7 cycloalkyl, C 1 -C 4 alkoxy, C 3 -C 6 cycloalkyloxy, C 3 -C 6 cycloalkylthio, C 6 -C 12 aryloxy, amino, mono or di-C 1 -C 8 alkylamino, thio C 1 -C 4 alkylthio, C 6 -C 12 arylthio, C 7 -C 16 aralkylthio, or the radical --S--(CH 2 ) n --CH(NH 2 )COOH.
Claim 2
Dependent Claim 373 words
A DHP inhibiting compound of Formula II: ##STR54## wherein R 1 is (a) C 2 -C 12 linear or branched unsubstituted alkyl; (b) C 2 -C 12 linear or branched substituted alkyl; (c) C 2 -C 12 linear or branched monoalkenyl; (d) C 2 -C 12 linear or branched alkynyl; (e) C 7 -C 20 aralkyl, wherein the alkyl chain is linear or branched C 1 -C 8 where N is 1 or 2 and the aryl moiety is C 6 -C 12 ; (f) C 3 -C 7 cycloalkyl; (g) C 4 -C 10 cycloalkylalkyl; wherein said above values for R 1 , excluding (a), can be substituted by one or more: C 1 -C 4 alkoxy, C 3 -C 6 cycloalkyloxy, C 3 -C 6 cycloalkylthio, C 6 -C 12 aryloxy, C 1 -C 4 alkylthio, C 6 -C 12 arylthio, C 7 -C 10 aralkyloxy, C 7 -C 16 aralkylthio; R 5 is (a) H or C 1 -C 12 linear or branched alkyl; (b) C 2 -C 12 linear or branched monoalkenyl; (c) C 7 -C 20 aralkyl, wherein the alkyl chain is linear or branched C 1 -C 8 and the aryl moiety is C 6 -C 12 ; (d) heterocyclic alkyl, wherein the alkyl chain is linear or branched C 1 -C 8 and the heterocyclic ring is 5-6 membered, aromatic, and containing 1-2 heteroatoms selected from the group consisting of O, N and S; (e) heterocyclic alkyl, wherein the alkyl chain is linear or branched C 1 -C 8 and the heterocyclic ring is 5-6 membered, aromatic, containing 1-2 heteroatoms selected from the group consisting of O, N and S, and the heterocyclic ring is fused with a benzene ring; wherein said above values for R 5 can be substituted by one or more: halo, hydroxy, carboxy, C 1 -C 4 alkoxycarbonyl, C 7 -C 16 arylalkoxycarbonyl, C 3 -C 7 cycloalkyl, C 1 -C 4 alkoxy, C 3 -C 6 cycloalkyloxy, C 3 -C 6 cycloalkylthio, C 6 -C 12 aryloxy, amino, mono or di-C 1 -C 8 alkylamino, thio C 1 -C 4 alkylthio, C 6 -C 12 arylthio, C 7 -C 16 aralkylthio, or the radical --S--(CH 2 ) n --CH(NH 2 )COOH.
Claim 3
Dependent Claim 14 words
The compound of claim 1 wherein R 1 is cyclohexylmethyl, isobutyl, benzyl, or n-pentyl.
Claim 4
Dependent Claim 175 words
The compound of claim 1 wherein: R 5 is (a) C 1 -C 12 linear or branched alkyl; (b) C 2 -C 12 linear or branched monoalkenyl; (c) C 7 -C 20 aralkyl, wherein the alkyl chain is linear or branched C 1 -C 8 and the aryl moiety is C 6 -C 12 ; (d) heterocyclic alkyl, wherein the alkyl chain is linear or branched C 1 -C 8 and the heterocyclic ring is 5-6 membered, aromatic and containing 1-2 heteroatoms selected from the group consisting of O, N and S; (e) heterocyclic alkyl, wherein the alkyl chain is linear or branched C 1 -C 8 and the heterocyclic ring is 5-6 membered aromatic containing 1-2 heteroatoms selected from the group consisting of O, N and S, and the heterocyclic ring is fused with a benzene ring; wherein said above values from R 5 can be substituted by one or more: halo, hydroxy, carboxy, C 1 -C 4 alkoxycarbonyl, C 7 -C 16 aralkylthio, or the radical --S--(CH 2 ) n --CH(NH 2 )COOH.
Claim 5
Dependent Claim 29 words
The compound of claim 3 in which the stereochemical configuration of the carbon attached to R 1 is (R) or (SR) and R 5 is in the "Z" configuration.
Claim 6
Dependent Claim 46 words
The compound of claim 1 being: (1-amino-2-cyclohexylethyl) 2-carboxy-4-methyl-(E & Z)-2-butenyl phosphinic acids; (1amino-2-cyclohexylethyl) 2-carboxy-3(Z)-cyclohexyl-2-butenyl phosphinic acid; (1-aminohexyl) 2-carboxy-2(Z)-octenyl phosphinic acid; (1-aminohexyl) 2-carboxy-4-cyclopentyl-2(Z)-butenyl phosphinic acid; (1-amino-2-cyclohexylethyl) 2-carboxy-2(Z)-octenyl phosphinic acid; (1-amino-2-cyclohexylethyl) 2-carboxy-4-cyclopentyl-2 (Z)-butenyl phosphinic acid; (1-aminohexyl) 2-carboxy-3-cyclohexyl-2(Z)-butenyl phosphinic acid; [1(R)-amino-2-cyclohexylethyl]-2-carboxy-4-methyl-2 (Z)-butenylphosphinic acid; [1(R)-amino-2-cyclohexylethyl]-2-carboxy-3(Z)-cyclohexyl-2-propenyl phosphinic acid; [1(R)-amino-2-cyclohexylethyl]-2-carboxy-4-cyclopentyl-2(Z)-butenyl phosphinic acid.

References Cited (Backward Citations)

US4147780A Cited
US4160452A Cited
US4256108A Cited
US4265874A Cited
US4539208A Cited
US4374131A Cited
US4416833A Cited
EP0091594A1 Cited
EP0161546A1 Cited
EP0209848A2 Cited
EP0210545A2 Cited
US4715994A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-09-08 1996-03-09 1996-09-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-09-08 2000-03-09 2000-09-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-09-08 2004-03-09 2004-09-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag